PolyPid Sets Oct. 28 Investor Day, Updates on D-PLEX100 Review

PolyPid will host a virtual Investor Day on Oct. 28, 2026, outlining its 2030 strategy and updating on D-PLEX100, which is under FDA Priority Review with a PDUFA goal of Nov. 28, 2026. The company will also introduce PD01B for diabetic foot infections.